Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
192
-
Total 13F shares, excl. options
-
45.8M
-
Shares change
-
+8.03M
-
Total reported value, excl. options
-
$2B
-
Value change
-
+$319M
-
Put/Call ratio
-
0.3
-
Number of buys
-
141
-
Number of sells
-
-69
-
Price
-
$43.79
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q2 2019
261 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q2 2019.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.8M shares
.
Largest 10 shareholders include STIFEL FINANCIAL CORP (2.84M shares), BlackRock Inc. (2.49M shares), RP Management, LLC (2.11M shares), ORACLE INVESTMENT MANAGEMENT INC (1.67M shares), STATE STREET CORP (1.59M shares), Cormorant Asset Management, LP (1.55M shares), JPMORGAN CHASE & CO (1.55M shares), ALLIANCEBERNSTEIN L.P. (1.41M shares), Capital International Investors (1.39M shares), and CITADEL ADVISORS LLC (1.29M shares).
This table shows the top 192 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.